carcinoma

Showing 76 - 100 of 189

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Cancer, Ovarian and Fallopian Tube Cysts and Tumors, Tumors by Site Trial in Nanjing (Anlotinib, Olaparib)

Recruiting
  • Ovarian Cancer
  • +18 more
  • Nanjing, Jangsu, China
    JiangSu Cancer Hospital
Oct 29, 2020

Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial in Worldwide (Sym004, Futuximab, Modotuximab)

Terminated
  • Metastatic Colorectal Cancer
  • +2 more
  • Duarte, California
  • +17 more
Sep 7, 2020

Carcinoma, Advanced Cancer Trial in Grand Rapids, San Antonio (TRX-818 capsules)

Completed
  • Carcinoma
  • Advanced Cancer
  • TRX-818 capsules
  • Grand Rapids, Michigan
  • +1 more
May 19, 2020

Carcinoma, Transitional Cell Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Israel, United States

Withdrawn
  • Carcinoma
  • +2 more
  • UGN-101 instillations
  • Los Angeles, California
  • +4 more
May 5, 2020

Assessment of Patient Experience During Treatment for Cancer

Completed
  • Carcinoma
    • Palo Alto, California
      Stanford University, School of Medicine
    Apr 27, 2020

    Carcinoma, Sarcoma, Myeloma Trial in New York (radiation, procedure, other)

    Completed
    • Carcinoma
    • +4 more
    • [18F]-SKI-249380
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 24, 2020

    Carcinoma, Non-small-cell Lung Cancer, Lung Tumors Trial in Beijing

    Completed
    • Carcinoma
    • +2 more
      • Beijing, Beijing, China
        Peking University People's Hospital
      Mar 26, 2020

      Carcinoma, NSCLC Trial in Columbia (Karenitecin (BNP1350))

      Completed
      • Carcinoma
      • Carcinoma, Non-Small-Cell Lung
      • Karenitecin (BNP1350)
      • Columbia, Missouri
        Ellis Fischel Cancer Center
      Mar 10, 2020

      What Benefit ofFull Analysis of Exome? Routine Care Study in

      Completed
      • Carcinoma
        • Dijon, France
          CGFL
        Nov 19, 2019

        Carcinoma, NSCLC Trial (sintilimab plus anlotinib, Chemotherapy)

        Unknown status
        • Carcinoma
        • Non-small Cell Lung Cancer
        • (no location specified)
        Oct 10, 2019

        Carcinoma, Neuroendocrine Tumors Trial in United States (Cixutumumab, depot octreotide)

        Completed
        • Carcinoma
        • Neuroendocrine Tumors
        • Cixutumumab
        • depot octreotide
        • Los Angeles, California
        • +9 more
        Sep 6, 2019

        Peritoneal Carcinomatosis, Colorectal Cancer, Carcinoma Trial in Nijmegen (drug, radiation, procedure)

        Unknown status
        • Peritoneal Carcinomatosis
        • +4 more
        • Indium-111-DOTA-Labetuzumab-IRDye800CW injection
        • +2 more
        • Nijmegen, Netherlands
          Radboudumc
        Sep 12, 2019

        Identifying Genomic Mutations of Multiple Primary Lung Cancers

        Unknown status
        • Carcinoma
        • +2 more
          • (no location specified)
          Aug 26, 2019

          Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell

          Completed
          • Carcinoma
          • +4 more
          • Biological sample
          • Bordeaux, France
            University Bordeaux Hospital
          Aug 2, 2019

          Mixed Tumor, Malignant, Biopsy, Resection Trial (Optical Coherence Tomography (OCT) with Vivosight, Optical Coherence Tomography

          Withdrawn
          • Mixed Tumor, Malignant
          • +4 more
          • Optical Coherence Tomography (OCT) with Vivosight
          • Optical Coherence Tomography (OCT) with Skintell
          • (no location specified)
          Apr 2, 2019

          Carcinoma, Advanced Cancer Trial in Tainan City (TRX-818 capsules)

          Completed
          • Carcinoma
          • Advanced Cancer
          • TRX-818 capsules
          • Tainan City, Tainan, Taiwan
            National Cheng Kung University Hospital
          Mar 27, 2019

          Cancer, Carcinoma, Solid Tumors Trial in Baltimore, Charleston, Charlottesville (Ceramide NanoLiposome)

          Unknown status
          • Cancer
          • +3 more
          • Ceramide NanoLiposome
          • Baltimore, Maryland
          • +2 more
          Feb 26, 2019

          Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial (Sym004, TAS-102)

          Withdrawn
          • Metastatic Colorectal Cancer
          • +2 more
          • (no location specified)
          Jan 31, 2019

          Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoma, Neuroendocrine Trial in Worldwide (Everolimus)

          Completed
          • Advanced and Metastatic Silent Neuro-Endocrine Tumors
          • +6 more
          • Bordeaux, France
          • +39 more
          Aug 14, 2018

          Small Pulmonary Nodules by Multi-omics Sequencing

          Completed
          • Carcinoma
          • +2 more
            • Beijing, Beijing, China
              Peking University People's Hospital
            Jan 8, 2019

            Carcinoma, Lung Tumor, Small Cell Lung Cancer Trial in Shijiazhuang (Anlotinib Hydrochloride)

            Unknown status
            • Carcinoma
            • +2 more
            • Anlotinib Hydrochloride
            • Shijiazhuang, Hebei, China
              The First Hospital of Shijiazhuang
            Dec 19, 2018

            Carcinoma, NSCLC, Lung Tumor Trial in Shijiazhuang (Sintilimab, Anlotinib Hydrochloride)

            Unknown status
            • Carcinoma
            • +2 more
            • Sintilimab
            • Anlotinib Hydrochloride
            • Shijiazhuang, Hebei, China
              The First Hospital of Shijiazhuang
            Dec 5, 2018

            NSCLC, Carcinoma, NSCLC Trial in New York (Ensartinib, Durvalumab)

            Completed
            • Non-small Cell Lung Cancer
            • +2 more
            • New York, New York
              Research Facility
            Oct 25, 2018

            Stage III-IV Lung Cancer Patients

            Unknown status
            • Carcinoma
            • +2 more
              • Beijing, Beijing, China
              • +7 more
              Nov 9, 2018

              Prostatic Diseases, Genital Tumors, Male, Urogenital Tumors Trial in Los Angeles (Ixabepilone)

              Terminated
              • Prostatic Diseases
              • +7 more
              • Los Angeles, California
                Cedars-Sinai Medical Center
              Oct 22, 2018